©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 132-143
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.132
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.132
Table 1 Baseline characteristics reported as n (%) or mean (SD)
| Variable | Overall cohort (n = 91) |
| Age | 51 (12.1) |
| Sex (male) | 68 (74.7) |
| Presenting symptom | |
| Jaundice | 21 (23.1) |
| Fever | 11 (12.1) |
| Abdominal pain | 14 (15.4) |
| Asymptomatic | 21 (25) |
| Liver biopsy performed first | 51 (56) |
| Percutaneous liver biopsy | 65 (71.4) |
| Bile duct diameter (mm) | 4.6 (1.9) |
| R factor | 2 (2.4), Range: 0.1-6.4 |
| Alkaline phosphatase (international units/liter) | 392.6 (248.4) |
| AST (units/liter) | 200.5 (674.8) |
| ALT (units/liter) | 205.4 (444.2) |
| Total bilirubin (mg/dL) | 4.5 (5.4) |
| Deceased donor | 73 (80.2) |
| Transplant biliary anatomy | |
| Duct-to-duct | 67 (73.6) |
| Roux-en-Y hepaticojejunostomy | 24 (26.4) |
| Tacrolimus | 66 (73.3) |
| Sirolimus | 20 (22.2) |
| Everolimus | 6 (6.6) |
| Mycophenolate sodium | 28 (31.1) |
| Mycophenolate mofetil | 13 (14.4) |
| Cyclosporine | 16 (17.8) |
| Prednisone | 20 (22.2) |
| Immunosuppression monotherapy | 20 (22) |
| Dual immunosuppression therapy | 68 (74.7) |
| Triple immunosuppression therapy | 3 (3.3) |
- Citation: Attwell A, Han S, Kriss M. Endoscopic retrograde cholangiopancreatography and liver biopsy in the evaluation of elevated liver function tests after liver transplantation. World J Hepatol 2021; 13(1): 132-143
- URL: https://www.wjgnet.com/1948-5182/full/v13/i1/132.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i1.132